GlassScriptPhysician profile
Diaa Mikhail
NPI 1558391227
$14,848.69
in general payments reported to CMS, 2019-2025
48 companies · $1,191 in 2025
The $1,191 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,346 · 2020: $2,555 · 2021: $2,931 · 2022: $2,312 · 2023: $1,742 · 2024: $1,771 · 2025: $1,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,610 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,609.72 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,809.33 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $1,713.10 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,575.86 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $1,398.02 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $836.31 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $810.49 | 2019-2023 | |
| Pfizer INC. | $732.75 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $563.74 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $531.27 | 2021-2025 | |
| Amgen INC. | $518.93 | 2019-2025 | Otezla, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $461.68 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $355.59 | 2019-2021 | |
| Astellas Pharma US INC | $311.10 | 2019-2023 | |
| Dexcom, INC. | $290.11 | 2020-2025 | Dexcom G6 Transmitter |
| Sunovion Pharmaceuticals INC. | $282.94 | 2019-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diaa Mikhail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.